Achieve Life Sciences Quarterly Balance Sheet
NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Achieve Life Sciences financial position
As of Sep 30, 2026, Achieve Life Sciences reported total assets of $206.4 million, up 296.7% from a year earlier against total liabilities of $25.7 million. Shareholders' equity stood at $180.7 million, or 87.6% of assets. The company held $59.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 10.49, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Achieve Life Sciences balance sheet (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 59.74M | 47.96M | 28.08M | 20.93M | 31.93M | 51.87M | 13.02M | 12.75M | 9.54M | 14.76M | 66.40M | 15.55M |
| Short-Term Investments | 141.78M | 139.34M | 1.19M | 15.47M | 16.18M | 3.52M | 10.23M | 21.61M | 33.37M | 46.56M | — | — |
| Total Current Assets | 203.41M | 188.29M | 31.06M | 39.89M | 50.05M | 56.90M | 25.00M | 36.47M | 45.53M | 62.52M | 67.71M | 16.98M |
| Property, Plant & Equipment | — | — | — | 3.00K | — | — | — | 8.00K | — | — | — | 13.00K |
| Goodwill | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M |
| Intangible Assets | 584.00K | 640.00K | 696.00K | 751.00K | 807.00K | 863.00K | 918.00K | 974.00K | 1.03M | 1.09M | 1.14M | 1.20M |
| Total Assets | 206.42M | 190.44M | 33.10M | 41.79M | 52.04M | 58.94M | 27.36M | 38.63M | 47.92M | 64.79M | 70.03M | 19.37M |
| Accounts Payable | — | — | — | — | 1.94M | 1.22M | 1.66M | 1.95M | 1.01M | 550.00K | 373.00K | 618.00K |
| Total Current Liabilities | 19.39M | 197.66M | 11.83M | 9.08M | 9.73M | 8.57M | 7.13M | 6.68M | 6.72M | 13.70M | 20.57M | 20.81M |
| Total Liabilities | 25.69M | 205.12M | 22.43M | 20.27M | 18.43M | 17.27M | 17.08M | 17.73M | 16.54M | 22.51M | 20.57M | 20.82M |
| Shareholders' Equity | 180.73M | -14.68M | 10.68M | 21.52M | 33.62M | 41.67M | 10.28M | 20.90M | 31.38M | 42.28M | 49.46M | -1.45M |
| Retained Earnings | -357.27M | -345.16M | -270.39M | -260.23M | -245.56M | -231.12M | -218.41M | -205.58M | -193.22M | -180.71M | -172.25M | -165.75M |
| Net Cash (Debt) | 201.52M | 187.30M | 29.27M | 36.40M | 48.11M | 55.40M | 23.25M | 34.36M | 42.91M | 61.31M | 66.40M | 15.55M |
| Shares Outstanding | 109.78M | 102.72M | 53.24M | 53.23M | 52.81M | 49.69M | 34.69M | 34.69M | 34.39M | 34.34M | 34.25M | 21.17M |
This table shows 12 quarterly periods of Achieve Life Sciences's balance sheet, from Q3 2026 back to Q4 2023, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow QUIT's reporting calendar. What is a balance sheet?